Enimmune corporation(TW:6564)
NT$14.90+-0.05 (+8.36%)
TW:6564
Enimmune corporation financials statements
NT$14.90
At close:+-0.05 (+8.36%)
Enimmune corporation (6564) Income Statement
Enimmune corporation Income Statement
Last quarter (Q2 2026), Enimmune corporation's total revenue was NT$27.90M, an increase of 68.04% from the same quarter last year. In Q2, Enimmune corporation's net income was NT$-49.02M. See Enimmune corporation’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 48.19M | NT$ 39.91M | NT$ 43.49M | NT$ 188.41M | NT$ 109.82M | |
| NT$ 8.02M | NT$ 14.23M | NT$ -23.37M | NT$ 20.84M | NT$ 38.72M | |
| NT$ 193.26M | NT$ 165.51M | NT$ 220.10M | NT$ 307.26M | NT$ 97.33M | |
| Depreciation and Amortization | NT$ 9.07M | NT$ 7.60M | NT$ 7.75M | NT$ 8.35M | NT$ 8.62M |
| NT$ -176.17M | NT$ -155.78M | NT$ -228.96M | NT$ -258.42M | NT$ -38.40M | |
| NT$ -185.24M | NT$ -151.29M | NT$ -243.47M | NT$ -286.42M | NT$ -58.67M | |
| NT$ 20.70M | NT$ -14.29M | NT$ 5.79M | NT$ 19.33M | NT$ 11.43M | |
| NT$ -164.54M | NT$ -165.57M | NT$ -237.69M | NT$ -267.09M | NT$ -47.25M | |
| NT$ -164.54M | NT$ -157.55M | NT$ -223.74M | NT$ -247.96M | NT$ -47.25M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ -2.28 | NT$ -2.20 | NT$ -3.40 | NT$ -3.88 | NT$ -0.79 |
| Diluted EPS | NT$ -2.28 | NT$ -2.20 | NT$ -3.40 | NT$ -3.88 | NT$ -0.79 |
| Weighted Average Shares Outstanding | 72.08M | 71.52M | 65.81M | 63.98M | 60.20M |
| Weighted Average Shares Outstanding (Diluted) | 72.08M | 71.52M | 65.81M | 63.98M | 60.20M |
Currency in TWD

